Antimalarial compound identification and design: advances in the patent literature, 2000 – 2003

Author： Waters Norman C   Dow Geoffrey S   Kozar Michael P  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.8, 2004-08, pp. : 1125-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic ligands for peroxisome proliferator-activated receptor-α, review of the patent literature 2000 – 2003

By Miyachi Hiroyuki  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 607-618

Informa Healthcare

Access to resources Recommend Favorite

Novel FabH inhibitors: a patent and article literature review (2000 – 2012)

By Luo Yin   Yang Yu-Shun   Fu Jie   Zhu Hai-Liang  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 11, 2012-11 ,pp. : 1325-1336

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibitors 2001. Patent and literature activity 2000 - September 2001

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2002-01 ,pp. : 93-112

Informa Healthcare

Access to resources Recommend Favorite

β-Lactamase inhibitors: a survey of the patent literature 2000 – 2004

By Phillips Oludotun A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 319-331

Informa Healthcare

Access to resources Recommend Favorite

New anti-Mycobacterium agents: recent advances in patent literature

By Terreni M.   Villani P.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 261-268

Informa Healthcare

Access to resources Recommend Favorite